- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Wave Life Sciences Ltd (WVE)
Wave Life Sciences Ltd stock price live, this page displays NASDAQ WVE stock exchange data. View the WVE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Wave Life Sciences Ltd real time stock price chart below.
What Is the Wave Life Sciences Ltd Stock Price Today?
The Wave Life Sciences Ltd stock price today is 8.130.
What Is the Stock Symbol for Wave Life Sciences Ltd?
The stock symbol for Wave Life Sciences Ltd is ""WVE.""
What Stock Exchange Does Wave Life Sciences Ltd Trade On?
Wave Life Sciences Ltd is listed and trades on the NASDAQ stock exchange.
Is Wave Life Sciences Ltd a Good Stock to Buy?
Determining whether Wave Life Sciences Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WVE quote. (ISIN: SG9999014716)
What Is the Wave Life Sciences Ltd Stock Price Today?
The Wave Life Sciences Ltd stock price today is 8.130.
What Is the Stock Symbol for Wave Life Sciences Ltd?
The stock symbol for Wave Life Sciences Ltd is ""WVE.""
What Stock Exchange Does Wave Life Sciences Ltd Trade On?
Wave Life Sciences Ltd is listed and trades on the NASDAQ stock exchange.
Is Wave Life Sciences Ltd a Good Stock to Buy?
Determining whether Wave Life Sciences Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WVE quote. (ISIN: SG9999014716)
8.130
-0.420(-4.91%)
Closed·
After Hours
8.350+0.220(+2.71%)
·
Fair Value
An estimate of a Wave Life Sciences Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.110
8.600
52 wk Range
5.040
16.735
WVE Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
WVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Wave Life Sciences Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.1108.600
52 wk Range
5.04016.735
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
WVE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Wave Life Sciences Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
20.188
Upside
+148.31%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Wave Life Sciences Ltd Company Profile
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company’s RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, an RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-N531, an exon skipping oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington’s disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.
Wave Life Sciences Ltd SWOT Analysis
RNA Editing Pionee | Wave Life Sciences leads in RNA-based therapeutics, with a proprietary editing platform showing promise in early human trials for genetic disorders |
AATD Breakthrough | Explore WVE-006's success in alpha-1 antitrypsin deficiency, demonstrating significant AAT level increases and validating RNA editing's potential |
Diverse Pipeline | From DMD to obesity, Wave's expansive portfolio showcases the versatility of its RNA editing technology across multiple high-value indications |
Market Outlook | Analyst price targets range from $9 to $36, reflecting the potential and risks in Wave's innovative approach to genetic medicine |
Wave Life Sciences Ltd Earnings Call Summary for Q3/2024
- Positive interim results for DMD candidate WVE-N531; full 48-week data expected Q1 2025
- Select HD trial showed ~50% mutant gene silencing; IND application planned for H2 2025
- Obesity program WVE-007 to enter clinical trials early 2025; breakthrough data for AATD candidate WVE-006
- Regulatory focus on dystrophin as DMD biomarker and caudate atrophy for HD; seeking accelerated approval pathways
- Transformative outlook for 2025 with key milestones; engaging potential partners after Takeda opt-out
Last Updated: 13/11/2024, 10:26
Read Full TranscriptCompare WVE to Peers and Sector
Metrics to compare | WVE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWVEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.0x | 2.0x | −0.5x | |
PEG Ratio | 0.30 | 0.06 | 0.00 | |
Price/Book | 9.3x | 1.5x | 2.6x | |
Price / LTM Sales | 13.8x | 3.0x | 3.3x | |
Upside (Analyst Target) | 139.8% | 71.1% | 43.4% | |
Fair Value Upside | Unlock | 9.8% | 7.1% | Unlock |
Analyst Ratings
15 Buy
1 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 20.188
(+148.31% Upside)
Earnings
Latest Release
Jul 30, 2025
EPS / Forecast
-0.31 / -0.27
Revenue / Forecast
8.70M / 14.31M
People Also Watch
FAQ
What Stock Exchange Does Wave Life Sciences Ltd Trade On?
Wave Life Sciences Ltd is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Wave Life Sciences Ltd?
The stock symbol for Wave Life Sciences Ltd is "WVE."
What Is the Wave Life Sciences Ltd Market Cap?
As of today, Wave Life Sciences Ltd market cap is 1.29B.
What Is Wave Life Sciences Ltd's Earnings Per Share (TTM)?
The Wave Life Sciences Ltd EPS (TTM) is -0.84.
When Is the Next Wave Life Sciences Ltd Earnings Date?
Wave Life Sciences Ltd will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is WVE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Wave Life Sciences Ltd Stock Split?
Wave Life Sciences Ltd has split 0 times.
How Many Employees Does Wave Life Sciences Ltd Have?
Wave Life Sciences Ltd has 288 employees.
What is the current trading status of Wave Life Sciences Ltd (WVE)?
As of 08 Aug 2025, Wave Life Sciences Ltd (WVE) is trading at a price of 8.13, with a previous close of 8.55. The stock has fluctuated within a day range of 8.11 to 8.60, while its 52-week range spans from 5.04 to 16.74.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.